niacinamide has been researched along with MEA 2a in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
INDOVINA, I | 1 |
CAUSI, N | 1 |
Plaza-Menacho, I | 1 |
Mologni, L | 1 |
Sala, E | 1 |
Gambacorti-Passerini, C | 1 |
Magee, AI | 1 |
Links, TP | 1 |
Hofstra, RM | 1 |
Barford, D | 1 |
Isacke, CM | 1 |
2 other studies available for niacinamide and MEA 2a
Article | Year |
---|---|
[Metabolism of nicotinamide in man. II. Venous tolerance test in inflammatory processes].
Topics: Inflammation; Multiple Endocrine Neoplasia Type 2a; Niacin; Niacinamide; Veins | 1952 |
Sorafenib functions to potently suppress RET tyrosine kinase activity by direct enzymatic inhibition and promoting RET lysosomal degradation independent of proteasomal targeting.
Topics: Benzenesulfonates; Cell Line; Cell Line, Tumor; Cell Proliferation; Humans; Inhibitory Concentration | 2007 |